deCode teams with US Preventative Medicine
Icelandic company deCode Genetics has announced it has signed a Letter of Intent to offer its genetic testing products to US Preventative Medicine customers.
US Preventative Medicine is a Dallas based company. The company has developed a suite of prevention, early detection and chronic condition management products and services that improve health outcomes while reducing health care costs. It’s products are as follows:
“The signing of the letter of intent with DeCode is significant because we will be the first entity in the US and internationally to offer a full continuum of geographically dispersed, comprehensive solutions for personalized medicine,” Christopher Fey, chairman and CEO of US Preventive Medicine, said in a statement.
Elaine Warburton www.geneticsandhealth.com
Tags: deCode; US Preventative Medicine, DNA profiling, Genetic information and education, Genetic risk, Genetic Testing, Health insurance, personalized genomics services, Personalized MedicineRelated Stories
POSTED IN: DNA profiling, General Genetics and Health, Genetic Testing, Genetic information and education, Genetic risk, Health insurance, Personal Genomics Services, Personalized Medicine, deCode
.gif)
Recent Comments